Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEHR TEST SYSTEMSAEHR · Entity 2640 | Director | August 14, 2026 | August 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEHR TEST SYSTEMS
Report date August 14, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 140,667 |
Reported balance
After 2026-08-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-14 · Sale · Disposed 5,700 · Balance 140,667 F1: The amount reported includes shares subject to unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The amount reported includes shares subject to unvested restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 14, 2026 21:52 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,700 | $133.03 | $758,264.16 |
DisclosureSEC source: 0001040470-26-000257 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,667 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 01:16 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $108.30 | $2,165,922.00 |
DisclosureSEC source: 0001040470-26-000237 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,367 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 30, 2026 Filed Jul 30, 2026 23:52 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000231 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,367 F1 · shares: The shares were gifted to the Everett Drake Slayen Trust. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 21:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 1,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000175 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,367 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| May 13, 2026 Filed May 16, 2026 00:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 6,819 | $104.73 | $714,153.87 |
DisclosureSEC source: 0001654954-26-005019 · form4.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,709 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 22, 2026 Filed Apr 22, 2026 21:13 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000143 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,528 F1 · shares: The shares were donated to Donor Advised Charitable Giving Fund. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 17, 2026 Filed Apr 18, 2026 00:19 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 25,000 | $85.00 | $2,125,000.00 |
DisclosureSEC source: 0001040470-26-000122 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,328 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 01:34 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000050 · primary_01.xml · nonDerivative · entry 3 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,328 F3 · shares: The shares were gifted to the Max William Slayen Trust. F4 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 01:34 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000050 · primary_01.xml · nonDerivative · entry 2 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,328 F2 · shares: The shares were gifted to the Allison Elizabeth Slayen Trust. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 01:34 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000050 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,328 F1 · shares: The shares were gifted to the Leila James Slayen Trust. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:43 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 6,000 | $25.73 | $154,357.20 |
DisclosureSEC source: 0001040470-25-000080 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,328 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.99, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| September 24, 2025 Filed Sep 25, 2025 23:37 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-25-011127 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,328 F1 · shares: The shares were donated to Donor Advised Charitable Giving Inc. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 20:51 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 639 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-25-000988 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,328 F1 · shares: The shares were donated to California Association of CASAs. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 21:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 9,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-25-000829 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,967 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 02, 2024 Filed Aug 3, 2024 00:56 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | PurchaseCommon Stock | 20,000 | $15.50 | $310,000.00 |
DisclosureSEC source: 0001593968-24-001046 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,714 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 20:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 9,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000965 · primary_01.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,714 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 27, 2023 Filed Oct 28, 2023 01:46 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 4,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-013502 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,449 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 11, 2023 Filed Oct 12, 2023 00:10 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | PurchaseCommon Stock | 700 | $40.20 | $28,140.00 |
DisclosureSEC source: 0001654954-23-012814 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,989 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-010480 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,289 F1 · shares: The shares were donated to California Court Appointed Special Advocate Association. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 28, 2023 Filed Jul 31, 2023 20:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-009879 · section16.xml · nonDerivative · entry 3 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,439 F2 · shares: The shares were donated to San Francisco Jazz Organization F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 20:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 336 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-009879 · section16.xml · nonDerivative · entry 2 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,539 F1 · shares: The shares were donated to California Court Appointed Special Advocate Association. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 20:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,352 | $52.82 | $282,692.64 |
DisclosureSEC source: 0001654954-23-009879 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,875 Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 14,648 | $51.91 | $760,442.13 |
DisclosureSEC source: 0001654954-23-009741 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,227 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.90 to $51.965, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001654954-23-009269 · section16.xml · derivative · entry 10 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-11-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,711 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001654954-23-009269 · section16.xml · derivative · entry 9 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,711 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Total number of shares became exercisable on this date. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001654954-23-009269 · section16.xml · derivative · entry 8 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 16,160 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001654954-23-009269 · section16.xml · derivative · entry 7 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,160 shares Expires 2027-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Total number of shares became exercisable on this date. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-23-009269 · section16.xml · derivative · entry 6 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2027-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 10,000 | $1.34 | $13,400.00 |
DisclosureSEC source: 0001654954-23-009269 · section16.xml · nonDerivative · entry 5 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 14,711 | $1.86 | $27,362.46 |
DisclosureSEC source: 0001654954-23-009269 · section16.xml · nonDerivative · entry 4 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 16,160 | $1.64 | $26,502.40 |
DisclosureSEC source: 0001654954-23-009269 · section16.xml · nonDerivative · entry 3 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 10,000 | $1.77 | $17,700.00 |
DisclosureSEC source: 0001654954-23-009269 · section16.xml · nonDerivative · entry 2 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 10,000 | $2.03 | $20,300.00 |
DisclosureSEC source: 0001654954-23-009269 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2023 Filed Jul 12, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-009083 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,004 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 270 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-007915 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,004 F1 · shares: The shares were donated to Child Advocates of Silicon Valley. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001654954-23-004368 · section16.xml · derivative · entry 4 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001654954-23-004368 · section16.xml · derivative · entry 3 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-10-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 10,000 | $3.46 | $34,600.00 |
DisclosureSEC source: 0001654954-23-004368 · section16.xml · nonDerivative · entry 2 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 10,000 | $2.81 | $28,100.00 |
DisclosureSEC source: 0001654954-23-004368 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2022 Filed Dec 8, 2022 02:19 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-016220 · section16.xml · nonDerivative · entry 3 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,274 F3 · shares: The shares were donated to California CASA Association. F4 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| December 07, 2022 Filed Dec 8, 2022 02:19 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-016220 · section16.xml · nonDerivative · entry 2 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,774 F2 · shares: The shares were donated to Child Advocates of Silicon Valley. Read SEC document |
| December 07, 2022 Filed Dec 8, 2022 02:19 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-016220 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,874 F1 · shares: The shares were donated to Peninsula Open Space Trust. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 6,000 | $25.53 | $153,164.40 |
DisclosureSEC source: 0001654954-22-015433 · section16.xml · nonDerivative · entry 2 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,924 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.27 to $25.815, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F4 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 22,113 | $25.02 | $553,203.13 |
DisclosureSEC source: 0001654954-22-015433 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,924 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.235, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:52 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 19,887 | $25.01 | $497,379.84 |
DisclosureSEC source: 0001654954-22-015298 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,037 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.06, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 18,000 | $20.00 | $360,081.00 |
DisclosureSEC source: 0001654954-22-014023 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,924 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 22:36 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013921 · section16.xml · nonDerivative · entry 2 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,924 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 22:36 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013921 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,924 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 10,000 | $18.26 | $182,557.00 |
DisclosureSEC source: 0001654954-22-011497 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,762 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.34, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 10,000 | $17.50 | $175,002.00 |
DisclosureSEC source: 0001654954-22-011188 · section16.xml · nonDerivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,762 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.